Stock Comparison
ARGX vs ROIV
argenx NV ADR and Roivant Sciences Ltd side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$55.44B
$24.51B
P/E (TTM)
39.4
—
Forward P/E
34.0
—
Price/Sales
11.7
2,966.8
Price/Book
7.5
5.4
EV/EBITDA
33.9
0.7
Dividend Yield
—
—
Profitability
Net Margin
31.40%
0.00%
Operating Margin
30.00%
-14675.00%
Return on Equity
20.20%
-7.59%
Return on Assets
8.86%
-14.30%
Growth (YoY)
Revenue Growth
62.60%
-66.70%
Earnings Growth
114.00%
-96.10%
Price & Risk
Beta
-0.0
1.1
52-Week High
$934.62
$34.68
52-Week Low
$510.06
$10.71
Analyst Target
$1,041.14
$39.04
Compare ARGX and ROIV your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.